Bikam Pharmaceuticals


Public list: Pharma Startups (6570) Eye Health (703)

BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, there are approximately 1.5 million people which suffer from retinitis pigmentosa (RP), a hereditary disease which leads to blindness. As its initial priority, the company is pursuing the discovery of compounds based on a novel mechanism of action iden...Show all

BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, the...Show all

Company (Alive / Active)

Phone: 617-252-4343

Fax:

55 Cambridge Parkway
Suite 301
Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bikam Pharmaceuticals $11M Nov 23, 2007
See all 45 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bikam Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors

Board Members

Competitors

Company Status Description Investors

Innoviva

Brisbane, California, United States
IPO / Went publicInnoviva, formerly known as Theravance, is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible...Show allLogin to see details

Memory Pharmaceuticals

Montvale, New Jersey, United States
AcquiredMemory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.Login to see details
See all 45 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Opsin-binding ligands, compositions and methods of use Apr 21, 2016 Sep 12, 2017 Patent
Opsin-binding ligands, compositions and methods of use Jun 16, 2010 Feb 07, 2017 Patent
Opsin-binding ligands, compositions and methods of use Oct 19, 2012 Nov 22, 2016 Patent
Opsin-binding ligands, compositions and methods of use Aug 13, 2015 Oct 04, 2016 Patent
Opsin-binding ligands, compositions and methods of use Nov 27, 2012 May 31, 2016 Patent
See all 10 patents